Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib Plus Endocrine Therapy vs Chemotherapy in Rapidly Progressive HR+/HER2- Advanced Breast Cancer
NCT06375707Phase 2Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in breast cancer, sponsored by Jiangsu Provincial People's Hospital. Started Jan 2024; status: completed.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06375707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06375707.